GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Shiller PE Ratio

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Shiller PE Ratio : 21.04 (As of May. 17, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-17), Hubei Jumpcan Pharmaceutical Co's current share price is ¥39.56. Hubei Jumpcan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥1.88. Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio for today is 21.04.

The historical rank and industry rank for Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:600566' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.23   Med: 37.22   Max: 91
Current: 21.04

During the past years, Hubei Jumpcan Pharmaceutical Co's highest Shiller PE Ratio was 91.00. The lowest was 10.23. And the median was 37.22.

SHSE:600566's Shiller PE Ratio is ranked better than
58.72% of 533 companies
in the Drug Manufacturers industry
Industry Median: 25.16 vs SHSE:600566: 21.04

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hubei Jumpcan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.922. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.88 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hubei Jumpcan Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Shiller PE Ratio Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.60 15.30 18.57 17.18 17.39

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.37 17.24 15.68 17.39 19.90

Competitive Comparison of Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio falls into.



Hubei Jumpcan Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=39.56/1.88
=21.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Jumpcan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Hubei Jumpcan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.922/115.2271*115.2271
=0.922

Current CPI (Mar. 2024) = 115.2271.

Hubei Jumpcan Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.166 98.200 0.195
201409 0.158 98.900 0.184
201412 0.183 99.000 0.213
201503 0.204 99.900 0.235
201506 0.220 99.500 0.255
201509 0.215 100.500 0.247
201512 0.241 100.600 0.276
201603 0.268 102.200 0.302
201606 0.292 101.400 0.332
201609 0.292 102.400 0.329
201612 0.318 102.600 0.357
201703 0.359 103.200 0.401
201706 0.360 103.100 0.402
201709 0.402 104.100 0.445
201712 0.389 104.500 0.429
201803 0.574 105.300 0.628
201806 0.464 104.900 0.510
201809 0.570 106.600 0.616
201812 0.462 106.500 0.500
201903 0.623 107.700 0.667
201906 0.554 107.700 0.593
201909 0.419 109.800 0.440
201912 0.388 111.200 0.402
202003 0.568 112.300 0.583
202006 0.270 110.400 0.282
202009 0.337 111.700 0.348
202012 0.353 111.500 0.365
202103 0.489 112.662 0.500
202106 0.462 111.769 0.476
202109 0.467 112.215 0.480
202112 0.492 113.108 0.501
202203 0.642 114.335 0.647
202206 0.486 114.558 0.489
202209 0.639 115.339 0.638
202212 0.623 115.116 0.624
202303 0.739 115.116 0.740
202306 0.722 114.558 0.726
202309 0.658 115.339 0.657
202312 0.957 114.781 0.961
202403 0.922 115.227 0.922

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hubei Jumpcan Pharmaceutical Co  (SHSE:600566) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hubei Jumpcan Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hubei Jumpcan Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Traded in Other Exchanges
N/A
Address
Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines